Hypoactive Sexual Desire Disorder

Hypoactive sexual desire disorder (HSDD) involves a lack of motivation or interest in sexual activity or a loss of desire to initiate or participate in sexual activity. Individuals with HSDD often shown signs of distress, frustration, or worry about their lack of libido or sexual desire.

Quick Answer

What it is

Hypoactive sexual desire disorder (HSDD) involves a lack of motivation or interest in sexual activity or a loss of desire to initiate or participate in sexual activity. Individuals with HSDD often shown signs of distress, frustration, or worry about their lack of libido or sexual desire.

Key findings

  • Grade A: Sexual Desire (FSDS-DAO) (PT-141 (Bremelanotide))
  • Grade A: Sexual Distress (PT-141 (Bremelanotide))
  • Grade A: Sexually Satisfying Events (PT-141 (Bremelanotide))

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Hypoactive Sexual Desire Disorder

  • Supplements Studied:3
  • Research Trials:2
  • Total Participants:208
  • Top Supplement:Tribulus Terrestris (C)
2 trials
208 ppts
3 supps · 15 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

1.5-3g daily

Traditional adaptogen; may improve sexual desire in both men and women

8 studies | 400 participants
25-50mg daily (under medical supervision)

Precursor to sex hormones; may help if levels are low (especially in women)

10 studies | 500 participants

Supporting Stack (Tier 2)

2.5-5g daily

Nitric oxide precursor; supports blood flow to genital area

5 studies | 200 participants
120-240mg daily

Improves circulation; may help with antidepressant-induced sexual dysfunction

4 studies | 150 participants
250-750mg daily

Traditional use for libido; limited evidence but some positive trials in women

5 studies | 200 participants
300-600mg daily (standardized extract)

Adaptogen; may reduce stress and improve sexual function

4 studies | 150 participants

How It Works

Hypoactive Sexual Desire Disorder (HSDD) is characterized by persistently low sexual desire that causes personal distress. It can affect both men and women, though it's more commonly diagnosed in women.

KEY FEATURES:

Absent or reduced sexual desire
Causes personal distress or relationship difficulties
Not explained by other conditions, medications, or relationship issues
Present for at least 6 months

CONTRIBUTING FACTORS:

Hormonal: Low testosterone, menopause, thyroid disorders
Psychological: Depression, anxiety, stress, past trauma
Relationship: Communication issues, conflict, lack of intimacy
Medical: Chronic illness, fatigue, pain conditions
Medications: Antidepressants (common), birth control, blood pressure meds

IMPORTANT: HSDD benefits from comprehensive evaluation and often psychological support. This protocol is SUPPORTIVE ONLY.

MEDICAL TREATMENTS:

Women: Flibanserin (Addyi), bremelanotide (Vyleesi) - FDA approved
Women (postmenopausal): May consider testosterone (off-label)
Men: Testosterone replacement if low
Both: Treat underlying conditions, adjust medications

NON-MEDICATION APPROACHES:

Sex therapy/couples counseling
Mindfulness and stress reduction
Address relationship issues
Exercise (improves mood and body image)
Adequate sleep
Limit alcohol

* Maca and DHEA have the most evidence for improving desire.

* Adaptogens may help if stress is a factor.

* Address underlying causes first.

Expected timeline: Supplements may show benefit within 4-8 weeks. Comprehensive treatment including psychological factors often more effective.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

|
A
Sexual Desire (FSDS-DAO)
Two Phase 3 RECONNECT trials (n=1202) showed bremelanotide significantly improved desire scores on the FSDS-DAO (Female Sexual Distress Scale-Desire/Arousal/Orgasm) compared to placebo across all subgroups.
moderateImproves
A
Sexual Distress
Bremelanotide significantly decreased distress associated with low sexual desire in premenopausal women with HSDD in two Phase 3 randomized controlled trials.
moderateImproves
A
Sexually Satisfying Events
Sexually satisfying events increased by 0.7 per month with bremelanotide vs 0.2 with placebo in a 12-week dose-finding trial of 293 premenopausal women.
smallImproves
B
Long-Term Efficacy
During the 52-week open-label extension of RECONNECT, sustained improvements in HSDD symptoms were maintained with no new safety signals observed.
moderateImproves
C
Erections
Small Increase
1 study
smallImproves
?
Free Testosterone
1 study
Improves
?
High-density lipoprotein (HDL)
1 study
Improves
?
Low-density lipoprotein (LDL)
1 study
Improves
?
Serum DHEA
1 study
Improves
?
Sex Hormone Binding Globulin
1 study
Improves
?
Testosterone
1 study
Improves
?
Total cholesterol
1 study
Improves
?
Triglycerides
1 study
Improves
D
Libido
No effect
1 study
none
?
Penile Girth
1 study
Improves

Research Citations (67)

Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
(2026)
PMID: 40543759
2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns.
(2025)
PMID: 40518469
Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies.
(2025)
PMID: 41088800
Intravenous peptides and amino acids for erectile dysfunction: a narrative review of current applications and future directions.
(2025)
PMID: 40069591
A Comprehensive Review of Novel FDA-Approved Psychiatric Medications (2018-2022).
(2024)
PMID: 38646400
Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide
(2022)
PMID: 35230162
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder
(2022)
PMID: 36242769
Safety Profile of Bremelanotide Across the Clinical Development Program.
(2022)
PMID: 35147466
Management of Hypertension with Female Sexual Dysfunction.
(2022)
PMID: 35630054
Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials.
(2022)
PMID: 35170192

Related Conditions

Female Sexual Dysfunction

3 shared supplements · 29 outcomes

In women, “sexual dysfunction” encompasses many conditions related to one’s ability to have or enjoy sex. Sexual dysfunction may involve issues with desire, arousal, orgasm, or intercourse. Because the causes of sexual dysfunction vary, treatments for the condition also vary.

Erectile Dysfunction

3 shared supplements · 41 outcomes

Erectile dysfunction is a type of male sexual dysfunction characterized by difficulty achieving or maintaining an erection. Erectile dysfunction can be caused by nerve or blood vessel damage, obesity, smoking, or stress.

Type 2 Diabetes

2 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Male Sexual Dysfunction

2 shared supplements · 68 outcomes

In men, sexual dysfunction is typically related to problems with arousal, getting an erection, and/or ejaculating. Sexual dysfunction is complicated and can be caused my many things. Improving diet, exercising more, and identifying underlying factors are all important for treating sexual dysfunction.

Low Testosterone

2 shared supplements · 75 outcomes

Low testosterone results from a problem in the testicles or the brain and can cause low libido, muscle loss, and/or depressed mood. It is primarily treated with testosterone replacement therapy.

Weight Loss & Maintenance

1 shared supplement · 433 outcomes

This goal refers to people with a BMI >25 attempting to reach/maintain their ideal weight. While interventions that work for people with a BMI >25 may also work for people with a lower BMI, the context is often sufficiently different that this isn't assured.

Smoking Behavior

1 shared supplement · 2 outcomes

Smoking behavior refers to individual aspects of smoking that include frequency of daily smoking, timing of one’s first daily cigarette, and characteristics of the actual act of smoking like depth of inhalation, puff duration, and the amount of smoke in a puff.

Sexual Health

1 shared supplement · 44 outcomes

Sexual health is a state of physical, emotional, mental, and social well-being surrounding one’s sexuality. Someone who is sexually healthy has a positive approach to sexual relationships and is involved in pleasurable and safe sexual experiences.